neog - Neogen's E.Coli Test adopted by Japan Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan

NEOG 6.410

+7.2%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JP who wrote (59)	10/2/1997 9:01:00 PM
From: Ken Sims	of 441

As far as growth goes read a portion of a news quote from back in July - see below. Increase in kit sales has a great impact on the bottom line. I am a long term hold but if the p/e gets way out there I will sell. I bought in at $7 nine months ago and added at 6 5/8 after that but didn't have anymore to invest as it took off. Ken ======================= biz.yahoo.com LANSING, Mich., July 22 /PRNewswire/ 1997 ``If you exclude last year's restructuring charge and compare apples to apples, we generated a 300% improvement in earnings on a 24% increase in product sales,'' said Lon Bohannon, Neogen's chief financial officer. ``The high gross margins on diagnostic products result in significant bottom-line growth as sales increase. We continue to be enthusiastic about our future because we have really just begun to scratch the surface of sales potential for the meat, poultry and seafood markets.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next